Form D · Other Technology

Neroshield, Inc.

Bradenton, FL · CIK 0001952549

Offering snapshot reported May 28, 2025 · SEC filing

Reported sold: $5.79M
Investors reported: 22
Minimum accepted: $0
First sale: Oct 18, 2022

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$2,515,000 → $5,790,000
Reported investors21 → 22

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
May 28, 2025	Amendment	$5,790,000	$3,275,000vs Dec 12, 2023	22	SEC filing
Dec 12, 2023	Amendment	$2,515,000	$2,365,000vs Nov 2, 2022	21	SEC filing
Nov 2, 2022	Amendment	$150,000	-$150,000vs Oct 31, 2022	1	SEC filing
Oct 31, 2022	Initial	$300,000	No comparison	2	SEC filing

Offering details

Securities: Equity, Option to acquire
Exemptions: 06b
Duration over one year: Yes
Business combination: No

Sales commissions: $548K (estimated)
Finders' fees: $0
Form D file number: 021-463306

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
Colorado Financial Service	104343

Source: Form D, filed May 28, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Chester Aldridge	Director
Corey Cole	Director, Executive
David Maloney	Executive
Daniel Stammen	Director, Executive
Jordan Ziriada	Director, Executive

Issuer details

Industry: Other Technology (See others in industry)

Address:

7466 Cortez Rd West Suite 257
Bradenton, FL, 34210